A dual role for the anti-apoptotic Bcl-2 protein in cancer: Mitochondria versus endoplasmic reticulum

Biochimica et Biophysica Acta - Molecular Cell Research

Volumn 1843, Issue 10, 2014, Pages 2240-2252

  Akl, Haidar ^a   Vervloessem, Tamara ^a   Kiviluoto, Santeri ^a   Bittremieux, Mart ^a   Parys, Jan B ^a   De Smedt, Humbert ^a   Bultynck, Geert ^a  

^a LABORATORY OF MOLECULAR AND CELLULAR SIGNALING   (Belgium)

Author keywords

Apoptosis; Bcl 2; Cancer B cell; Cell cycle; Inositol 1,4,5 trisphosphate receptor

Indexed keywords

ANTINEOPLASTIC AGENT; BH3 MIMETIC AGENT; BH3 PROTEIN; BH4 DOMAIN TARGETING PEPTIDE; BH4 PROTEIN; CALCIUM; INOSITOL 1,4,5 TRISPHOSPHATE RECEPTOR; PROTEIN; PROTEIN BAK; PROTEIN BAX; PROTEIN BCL 2; UNCLASSIFIED DRUG;

AMINO TERMINAL SEQUENCE; APOPTOSIS; B LYMPHOCYTE; BINDING AFFINITY; BIOINFORMATICS; CALCIUM SIGNALING; CALCIUM TRANSPORT; CANCER CELL; CANCER GROWTH; CARCINOGENESIS; CELL CYCLE PROGRESSION; CELL FATE; CELL PROLIFERATION; CELL SURVIVAL; CHRONIC LYMPHATIC LEUKEMIA; ENDOPLASMIC RETICULUM; GENE OVEREXPRESSION; HUMAN; LARGE CELL LYMPHOMA; LEUKEMIA CELL; LYMPHOMA CELL; MALIGNANT NEOPLASTIC DISEASE; MITOCHONDRION; MOLECULAR BIOLOGY; MOLECULAR INTERACTION; NONHUMAN; PRIORITY JOURNAL; PROTEIN DOMAIN; REVIEW; TRANSCRIPTION REGULATION; UPREGULATION;

APOPTOSIS; BCL-2; CA(2+); CANCER B-CELL; CELL CYCLE; INOSITOL 1,4,5-TRISPHOSPHATE RECEPTOR;

APOPTOSIS; B-LYMPHOCYTES; CALCIUM; CALCIUM SIGNALING; CELL SURVIVAL; ENDOPLASMIC RETICULUM; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; INOSITOL 1,4,5-TRISPHOSPHATE; INOSITOL 1,4,5-TRISPHOSPHATE RECEPTORS; LEUKEMIA, LYMPHOCYTIC, CHRONIC, B-CELL; LYMPHOMA, LARGE B-CELL, DIFFUSE; MITOCHONDRIA; PROTEIN STRUCTURE, TERTIARY; PROTO-ONCOGENE PROTEINS C-BCL-2;

EID: 84904983087     PISSN: 01674889     EISSN: 18792596     Source Type: Journal    
DOI: 10.1016/j.bbamcr.2014.04.017     Document Type: Review

References (197)

1. Pegoraro L., Palumbo A., Erikson J., Falda M., Giovanazzo B., Emanuel B.S., Rovera G., Nowell P.C., Croce C.M. A 14;18 and an 8;14 chromosome translocation in a cell line derived from an acute B-cell leukemia. Proc. Natl. Acad. Sci. U. S. A. 1984, 81:7166-7170.
2. Tsujimoto Y., Finger L.R., Yunis J., Nowell P.C., Croce C.M. Cloning of the chromosome breakpoint of neoplastic B cells with the t(14;18) chromosome translocation. Science 1984, 226:1097-1099.
3. Vaux D.L., Cory S., Adams J.M. Bcl-2 gene promotes haemopoietic cell survival and cooperates with c-myc to immortalize pre-B cells. Nature 1988, 335:440-442.
4. Bonnefoy-Berard N., Aouacheria A., Verschelde C., Quemeneur L., Marcais A., Marvel J. Control of proliferation by Bcl-2 family members. Biochim. Biophys. Acta (BBA) - Mol. Cell Res. 2004, 1644:159-168.
5. Sanchez-Beato M., Sanchez-Aguilera A., Piris M.A. Cell cycle deregulation in B-cell lymphomas. Blood 2003, 101:1220-1235.
6. Davis R.E., Staudt L.M. Molecular diagnosis of lymphoid malignancies by gene expression profiling. Curr. Opin. Hematol. 2002, 9:333-338.
7. 3 receptors. Biochim. Biophys. Acta (BBA) - Rev. Cancer 2013, 1835:180-193.
8. 2+ transfer from the ER to mitochondria: when, how and why. Biochim. Biophys. Acta (BBA)-Bioenerg. 2009, 1787:1342-1351.
9. 2+ and apoptosis. Cell Calcium 2012, 52:36-43.
10. Giorgi C., Wieckowski M.R., Pandolfi P.P., Pinton P. Mitochondria associated membranes (MAMs) as critical hubs for apoptosis. Commun. Integr. Biol. 2011, 4:334-335.
11. 2+ release and beyond. Apoptosis 2007, 12:951-968.
12. Zha J., Harada H., Yang E., Jockel J., Korsmeyer S.J. Serine phosphorylation of death agonist Bad in response to survival factor results in binding to 14-3-3 not Bcl-Xl. Cell 1996, 87:619-628.
13. Marchi S., Patergnani S., Pinton P. The endoplasmic reticulum-mitochondria connection: one touch, multiple functions. Biochim. Biophys. Acta (BBA)-Bioenerg. 2013, 1837:461-469.
14. 2+ signals as causes or consequences of mitophagy induction. Autophagy 2013, 9:1677-1686.
15. 3 receptor-mitochondria connection in apoptosis and autophagy. Biochim. Biophys. Acta (BBA) - Mol. Cell Res. 2011, 1813:1003-1013.
16. Rong Y., Distelhorst C.W. Bcl-2 protein family members: versatile regulators of calcium signaling in cell survival and apoptosis. Annu. Rev. Physiol. 2008, 70:73-91.
17. 3Rs and beyond. Cell. Mol. Life Sci. 2013, 70:1171-1183.
18. Czabotar P.E., Lessene G., Strasser A., Adams J.M. Control of apoptosis by the BCL-2 protein family: implications for physiology and therapy. Nat. Rev. Mol. Cell Biol. 2013, 15:49-63.
19. Renault T.T., Chipuk J.E. Death upon a kiss: mitochondrial outer membrane composition and organelle communication govern sensitivity to Bak/Bax-dependent apoptosis. Chem. Biol. 2014, 21:114-123.
20. Lindner A.U., Concannon C.G., Boukes G.J., Cannon M.D., Llambi F., Ryan D., Boland K., Kehoe J., McNamara D.A., Murray F., Kay E.W., Hector S., Green D.R., Huber H.J., Prehn J.H. Systems analysis of Bcl-2 protein family interactions establishes a model to predict responses to chemotherapy. Cancer Res. 2013, 73:519-528.
21. Sarosiek K.A., Ni Chonghaile T., Letai A. Mitochondria: gatekeepers of response to chemotherapy. Trends Cell Biol. 2013, 23:612-619.
22. Doonan F., Cotter T.G. Morphological assessment of apoptosis. Methods 2008, 44:200-204.
23. Dhodapkar M.V., Dhodapkar K.M., Li Z. Role of chaperones and FcγR in immunogenic death. Curr. Opin. Immunol. 2008, 20:512-517.
24. Zaman S., Wang R., Gandhi V. Targeting the apoptosis pathway in hematologic malignancies. Leuk. Lymphoma 2014, 10.3109/10428194.10422013.10855307.
25. Wang L., Yang J.K., Kabaleeswaran V., Rice A.J., Cruz A.C., Park A.Y., Yin Q., Damko E., Jang S.B., Raunser S., Robinson C.V., Siegel R.M., Walz T., Wu H. The Fas-FADD death domain complex structure reveals the basis of DISC assembly and disease mutations. Nat. Struct. Mol. Biol. 2010, 17:1324-1329.
26. Chipuk J.E., Green D.R. How do Bcl-2 proteins induce mitochondrial outer membrane permeabilization?. Trends Cell Biol. 2008, 18:157-164.
27. Tait S.W., Green D.R. Mitochondria and cell death: outer membrane permeabilization and beyond. Nat. Rev. Mol. Cell Biol. 2010, 11:621-632.
28. Brunelle J.K., Letai A. Control of mitochondrial apoptosis by the Bcl-2 family. J. Cell Sci. 2009, 122:437-441.
29. Chipuk J.E., Moldoveanu T., Llambi F., Parsons M.J., Green D.R. The Bcl-2 family reunion. Mol. Cell 2010, 37:299-310.
30. Cheng E.H., Levine B., Boise L.H., Thompson C.B., Hardwick J.M. Bax-independent inhibition of apoptosis by Bcl-Xl. Nature 1996, 379:554-556.
31. Letai A., Bassik M.C., Walensky L.D., Sorcinelli M.D., Weiler S., Korsmeyer S.J. Distinct BH3 domains either sensitize or activate mitochondrial apoptosis, serving as prototype cancer therapeutics. Cancer Cell 2002, 2:183-192.
32. Sarosiek K.A., Chi X., Bachman J.A., Sims J.J., Montero J., Patel L., Flanagan A., Andrews D.W., Sorger P., Letai A. Bid preferentially activates Bak while Bim preferentially activates Bax, affecting chemotherapy response. Mol. Cell 2013, 51:751-765.
33. Llambi F., Green D.R. Apoptosis and oncogenesis: give and take in the Bcl-2 family. Curr. Opin. Genet. Dev. 2011, 21:12-20.
34. Colell A., Ricci J.E., Tait S., Milasta S., Maurer U., Bouchier-Hayes L., Fitzgerald P., Guio-Carrion A., Waterhouse N.J., Li C.W., Mari B., Barbry P., Newmeyer D.D., Beere H.M., Green D.R. GAPDH and autophagy preserve survival after apoptotic cytochrome c release in the absence of caspase activation. Cell 2007, 129:983-997.
35. Lartigue L., Kushnareva Y., Seong Y., Lin H., Faustin B., Newmeyer D.D. Caspase-independent mitochondrial cell death results from loss of respiration, not cytotoxic protein release. Mol. Biol. Cell 2009, 20:4871-4884.
36. Wang H.G., Rapp U.R., Reed J.C. Bcl-2 targets the protein kinase Raf-1 to mitochondria. Cell 1996, 87:629-638.
37. Shibasaki F., Kondo E., Akagi T., McKeon F. Suppression of signalling through transcription factor NF-AT by interactions between calcineurin and Bcl-2. Nature 1997, 386:728-731.
38. 2+ signaling and autophagy induction are interrelated. Autophagy 2011, 7:1472-1489.
39. Mekahli D., Bultynck G., Parys J.B., De Smedt H., Missiaen L. Endoplasmic-reticulum calcium depletion and disease. Cold Spring Harb. Perspect. Biol. 2011, 3:a004317.
40. 2+ signals in autophagy. Cell Calcium 2012, 52:44-51.
41. 3 receptor-binding partners in cell-death mechanisms. Wiley Interdiscip. Rev. Membr. Transp. Signal. 2012, 1:201-210.
42. 1-ATPase and subunit c of storage body in the mitochondrial permeability transition. Effect of the phosphorylation status of subunit c on pore opening. Cell Calcium 2014, 55:69-77.
43. Giorgio V., von Stockum S., Antoniel M., Fabbro A., Fogolari F., Forte M., Glick G.D., Petronilli V., Zoratti M., Szabo I., Lippe G., Bernardi P. Dimers of mitochondrial ATP synthase form the permeability transition pore. Proc. Natl. Acad. Sci. U. S. A. 2013, 110:5887-5892.
44. 0 ATP synthase in mitochondrial permeability transition. Cell Cycle 2013, 12(2013):674-683.
45. 2+ transfer to mitochondria. Cell 2010, 142:270-283.
46. Patergnani S., Suski J.M., Agnoletto C., Bononi A., Bonora M., De Marchi E., Giorgi C., Marchi S., Missiroli S., Poletti F., Rimessi A., Duszynski J., Wieckowski M.R., Pinton P. Calcium signaling around mitochondria associated membranes (MAMs). Cell Commun. Signal. 2011, 9:19.
47. de Brito O.M., Scorrano L. Mitofusin 2 tethers endoplasmic reticulum to mitochondria. Nature 2008, 456:605-610.
48. 2+ storage in health and disease: a dynamic equilibrium. Cell Calcium 2010, 47:297-314.
49. Rizzuto R., De Stefani D., Raffaello A., Mammucari C. Mitochondria as sensors and regulators of calcium signalling. Nat. Rev. Mol. Cell Biol. 2012, 13:566-578.
50. McCormack J.G., Denton R.M. The effects of calcium ions and adenine nucleotides on the activity of pig heart 2-oxoglutarate dehydrogenase complex. Biochem. J. 1979, 180:533-544.
51. 2+ signal transduction in mitochondria from INS-1 clonal beta-cells. J. Biol. Chem. 2009, 284:515-524.
52. Llorente-Folch I., Rueda C.B., Amigo I., del Arco A., Saheki T., Pardo B., Satrustegui J. Calcium-regulation of mitochondrial respiration maintains ATP homeostasis and requires ARALAR/AGC1-malate aspartate shuttle in intact cortical neurons. J. Neurosci. 2013, 33:13957-13971.
53. 3R. Nat. Cell Biol. 2005, 7:1021-1028.
54. 2+ signaling. J. Biol. Chem. 2010, 285:13678-13684.
55. 2+-mediated bioenergetics to promote autophagy. Genes Dev. 2012, 26:1041-1054.
56. Jayaraman T., Marks A.R. T cells deficient in inositol 1,4,5-trisphosphate receptor are resistant to apoptosis. Mol. Cell. Biol. 1997, 17:3005-3012.
57. Assefa Z., Bultynck G., Szlufcik K., Nadif Kasri N., Vermassen E., Goris J., Missiaen L., Callewaert G., Parys J.B., De Smedt H. Caspase-3-induced truncation of type 1 inositol trisphosphate receptor accelerates apoptotic cell death and induces inositol trisphosphate-independent calcium release during apoptosis. J. Biol. Chem. 2004, 279:43227-43236.
58. Khan M.T., Bhanumathy C.D., Schug Z.T., Joseph S.K. Role of inositol 1,4,5-trisphosphate receptors in apoptosis in DT40 lymphocytes. J. Biol. Chem. 2007, 282:32983-32990.
59. Steinmann C., Landsverk M.L., Barral J.M., Boehning D. Requirement of inositol 1,4,5-trisphosphate receptors for tumor-mediated lymphocyte apoptosis. J. Biol. Chem. 2008, 283:13506-13509.
60. 2+ signalling. Biol. Cell. 2008, 100:39-49.
61. 2+ release and apoptosis. Cell Death Dis. 2012, 3:e304.
62. 2+ release and apoptosis. Proc. Natl. Acad. Sci. U. S. A. 2008, 105:2427-2432.
63. 2+ signaling and apoptosis in a protein phosphatase-dependent manner. Cell Death Differ. 2013, 20:1631-1643.
64. Rojas-Rivera D., Hetz C. TMBIM protein family: ancestral regulators of cell death. Oncogene 2014, 10.1038/onc.2014.1036.
65. 3 receptor-interacting and -sensitizing protein. Cell Death Dis. 2012, 3:e367.
66. Lisbona F., Rojas-Rivera D., Thielen P., Zamorano S., Todd D., Martinon F., Glavic A., Kress C., Lin J.H., Walter P., Reed J.C., Glimcher L.H., Hetz C. Bax inhibitor-1 is a negative regulator of the ER stress sensor IRE1α. Mol. Cell 2009, 33:679-691.
67. Castillo K., Rojas-Rivera D., Lisbona F., Caballero B., Nassif M., Court F.A., Schuck S., Ibar C., Walter P., Sierralta J., Glavic A., Hetz C. Bax inhibitor-1 regulates autophagy by controlling the IRE1α branch of the unfolded protein response. EMBO J. 2011, 30:4465-4478.
68. Wei Y., Pattingre S., Sinha S., Bassik M., Levine B. JNK1-mediated phosphorylation of Bcl-2 regulates starvation-induced autophagy. Mol. Cell 2008, 30:678-688.
69. Rojas-Rivera D., Armisen R., Colombo A., Martinez G., Eguiguren A.L., Diaz A., Kiviluoto S., Rodriguez D., Patron M., Rizzuto R., Bultynck G., Concha M.L., Sierralta J., Stutzin A., Hetz C. TMBIM3/GRINA is a novel unfolded protein response (UPR) target gene that controls apoptosis through the modulation of ER calcium homeostasis. Cell Death Differ. 2012, 19:1013-1026.
70. 3 receptor. Neuron 2010, 68:865-878.
71. Kiviluoto S., Vervliet T., Ivanova H., Decuypere J.P., De Smedt H., Missiaen L., Bultynck G., Parys J.B. Regulation of inositol 1,4,5-trisphosphate receptors during endoplasmic reticulum stress. Biochim. Biophys. Acta (BBA) - Mol. Cell Res. 2013, 1833:1612-1624.
72. 2+ influx that eventually results in loss of CD7 expression and activation of an antiapoptotic pathway involving Akt and Bad which paves the way for malignant transformation. Leukemia 2007, 21:788-796.
73. Akl H., Badran B., El Zein N., Dobirta G., Burny A., Martiat P. Deregulation of calcium fluxes in HTLV-I infected CD4-positive T-cells plays a major role in malignant transformation. Front. Biosci. 2009, 14:3925-3934.
74. Oh-hora M., Rao A. The calcium/NFAT pathway: role in development and function of regulatory T cells. Microbes Infect. 2009, 11:612-619.
75. Rao A., Luo C., Hogan P.G. Transcription factors of the NFAT family: regulation and function. Annu. Rev. Immunol. 1997, 15:707-747.
76. Crabtree G.R., Clipstone N.A. Signal transmission between the plasma membrane and nucleus of T lymphocytes. Annu. Rev. Biochem. 1994, 63:1045-1083.
77. Crabtree G.R., Olson E.N. NFAT signaling: choreographing the social lives of cells. Cell 2002, 109:S67-S79.
78. Macian F. NFAT proteins: key regulators of T-cell development and function. Nat. Rev. Immunol. 2005, 5:472-484.
79. Medyouf H., Alcalde H., Berthier C., Guillemin M.C., dos Santos N.R., Janin A., Decaudin D., de The H., Ghysdael J. Targeting calcineurin activation as a therapeutic strategy for T-cell acute lymphoblastic leukemia. Nat. Med. 2007, 13:736-741.
80. 2+ channel as a potential therapeutic treatment for neurological diseases. Pharm. Pat. Anal. 2013, 2:629-636.
81. 3R) and its regulators: sometimes good and sometimes bad teamwork. Sci. STKE 2006, 2006:re15.
82. 2+ for cancer cell proliferation and survival. Nat. Rev. Cancer 2008, 8:361-375.
83. Monteith G.R., Davis F.M., Roberts-Thomson S.J. Calcium channels and pumps in cancer: changes and consequences. J. Biol. Chem. 2012, 287:31666-31673.
84. Arbabian A., Brouland J.P., Gelebart P., Kovacs T., Bobe R., Enouf J., Papp B. Endoplasmic reticulum calcium pumps and cancer. Biofactors 2011, 37:139-149.
85. Prevarskaya N., Skryma R., Shuba Y. Calcium in tumour metastasis: new roles for known actors. Nat. Rev. Cancer 2011, 11:609-618.
86. Giorgi C., Ito K., Lin H.K., Santangelo C., Wieckowski M.R., Lebiedzinska M., Bononi A., Bonora M., Duszynski J., Bernardi R., Rizzuto R., Tacchetti C., Pinton P., Pandolfi P.P. PML regulates apoptosis at endoplasmic reticulum by modulating calcium release. Science 2010, 330:1247-1251.
87. Chen R., Valencia I., Zhong F., McColl K.S., Roderick H.L., Bootman M.D., Berridge M.J., Conway S.J., Holmes A.B., Mignery G.A., Velez P., Distelhorst C.W. Bcl-2 functionally interacts with inositol 1,4,5-trisphosphate receptors to regulate calcium release from the ER in response to inositol 1,4,5-trisphosphate. J. Cell Biol. 2004, 166:193-203.
88. Schulman J.J., Wright F.A., Kaufmann T., Wojcikiewicz R.J. The Bcl-2 protein family member Bok binds to the coupling domain of inositol 1,4,5-trisphosphate receptors and protects them from proteolytic cleavage. J. Biol. Chem. 2013, 288:25340-25349.
89. Kang S.S., Han K.S., Ku B.M., Lee Y.K., Hong J., Shin H.Y., Almonte A.G., Woo D.H., Brat D.J., Hwang E.M., Yoo S.H., Chung C.K., Park S.H., Paek S.H., Roh E.J., Lee S.J., Park J.Y., Traynelis S.F., Lee C.J. Caffeine-mediated inhibition of calcium release channel inositol 1,4,5-trisphosphate receptor subtype 3 blocks glioblastoma invasion and extends survival. Cancer Res. 2010, 70:1173-1183.
90. 2+ signalling is involved in estradiol-induced breast cancer epithelial cell growth. Mol. Cancer 2010, 9:156.
91. Shibao K., Fiedler M.J., Nagata J., Minagawa N., Hirata K., Nakayama Y., Iwakiri Y., Nathanson M.H., Yamaguchi K. The type III inositol 1,4,5-trisphosphate receptor is associated with aggressiveness of colorectal carcinoma. Cell Calcium 2010, 48:315-323.
92. Mound A., Rodat-Despoix L., Bougarn S., Ouadid-Ahidouch H., Matifat F. Molecular interaction and functional coupling between type 3 inositol 1,4,5-trisphosphate receptor and BKCa channel stimulate breast cancer cell proliferation. Eur. J. Cancer 2013, 49:3738-3751.
93. 3R1) modulates the acquisition of cisplatin resistance in bladder cancer cell lines. Oncogene 2005, 24:1396-1402.
94. Kaufmann T., Schlipf S., Sanz J., Neubert K., Stein R., Borner C. Characterization of the signal that directs Bcl-Xl, but not Bcl-2, to the mitochondrial outer membrane. J. Cell Biol. 2003, 160:53-64.
95. Hoetelmans R., van Slooten H.J., Keijzer R., Erkeland S., van de Velde C.J., Dierendonck J.H. Bcl-2 and Bax proteins are present in interphase nuclei of mammalian cells. Cell Death Differ. 2000, 7:384-392.
96. 2+ stores. J. Biol. Chem. 2002, 277:9219-9225.
97. 2+: a control point for apoptosis. Science 2003, 300:135-139.
98. Rodriguez D., Rojas-Rivera D., Hetz C. Integrating stress signals at the endoplasmic reticulum: the Bcl-2 protein family rheostat. Biochim. Biophys. Acta (BBA) - Mol. Cell Res. 2011, 1813:564-574.
99. Hetz C., Bernasconi P., Fisher J., Lee A.H., Bassik M.C., Antonsson B., Brandt G.S., Iwakoshi N.N., Schinzel A., Glimcher L.H., Korsmeyer S.J. Proapoptotic Bax and Bak modulate the unfolded protein response by a direct interaction with IRE1α. Science 2006, 312:572-576.
100. Rodriguez D.A., Zamorano S., Lisbona F., Rojas-Rivera D., Urra H., Cubillos-Ruiz J.R., Armisen R., Henriquez D.R., Cheng E.H., Letek M., Vaisar T., Irrazabal T., Gonzalez-Billault C., Letai A., Pimentel-Muinos F.X., Kroemer G., Hetz C. BH3-only proteins are part of a regulatory network that control the sustained signalling of the unfolded protein response sensor IRE1α. EMBO J. 2012, 31:2322-2335.
101. Hetz C., Glimcher L. The daily job of night killers: alternative roles of the Bcl-2 family in organelle physiology. Trends Cell Biol. 2008, 18:38-44.
102. Coe H., Michalak M. Calcium binding chaperones of the endoplasmic reticulum. Gen. Physiol. Biophys. 2009, 28:F96-F103. (Spec No Focus).
103. 2+ homeostasis and signaling. Endoplasmic Reticulum Stress in Health and Disease 2012, 107-142. Springer, Dordrecht Heidelberg New York London. P. Agostinis, A. Samali (Eds.).
104. 2+ fluxes. Proc. Natl. Acad. Sci. U. S. A. 1994, 91:6569-6573.
105. 2+ influx in Bcl-2-overexpressing cells. J. Cell Biol. 2000, 148:857-862.
106. 2+ concentration of the endoplasmic reticulum is a key determinant of ceramide-induced apoptosis: significance for the molecular mechanism of Bcl-2 action. EMBO J. 2001, 20:2690-2701.
107. 2+ pool depletion. Oncogene 1996, 12:2051-2055.
108. Oakes S.A., Scorrano L., Opferman J.T., Bassik M.C., Nishino M., Pozzan T., Korsmeyer S.J. Proapoptotic Bax and Bak regulate the type 1 inositol trisphosphate receptor and calcium leak from the endoplasmic reticulum. Proc. Natl. Acad. Sci. U. S. A. 2005, 102:105-110.
109. Minn A.J., Velez P., Schendel S.L., Liang H., Muchmore S.W., Fesik S.W., Fill M., Thompson C.B. Bcl-Xl forms an ion channel in synthetic lipid membranes. Nature 1997, 385:353-357.
110. Schendel S.L., Xie Z., Montal M.O., Matsuyama S., Montal M., Reed J.C. Channel formation by antiapoptotic protein Bcl-2. Proc. Natl. Acad. Sci. U. S. A. 1997, 94:5113-5118.
111. 2+ concentration within the endoplasmic reticulum. Proc. Natl. Acad. Sci. U. S. A. 2000, 97:5723-5728.
112. Li C., Wang X., Vais H., Thompson C.B., Foskett J.K., White C. Apoptosis regulation by Bcl-Xl modulation of mammalian inositol 1,4,5-trisphosphate receptor channel isoform gating. Proc. Natl. Acad. Sci. U. S. A. 2007, 104:12565-12570.
113. 3 receptor interaction to reverse Bcl-2's inhibition of apoptotic calcium signals. Mol. Cell 2008, 31:255-265.
114. 3 receptor. Proc. Natl. Acad. Sci. U. S. A. 2009, 106:14397-14402.
115. 2+ signals according to the strength of T cell receptor activation. J. Cell Biol. 2006, 172:127-137.
116. 2+ signaling and apoptosis by the BH4 domain of Bcl-2 versus Bcl-Xl. Cell Death Differ. 2012, 19:295-309.
117. 2+ homeostasis downstream of Bcl-2 family proteins. J. Biol. Chem. 2008, 283:11477-11484.
118. + antiporter-like activity of human recombinant Bax inhibitor-1 reconstituted into liposomes. FEBS J. 2009, 276:2285-2291.
119. 2+-permeable channel pore. J. Biol. Chem. 2012, 287:2544-2557.
120. 2+ uptake by mitochondria without affecting ER calcium store content. Cell Calcium 2008, 44:324-338.
121. 2+ signaling and disease. Cell Calcium 2011, 50:234-241.
122. 3 receptor. PLoS One 2013, 8:e73386.
123. 3 receptor interaction. Blood 2011, 117:2924-2934.
124. 3R-derived peptide targeting the BH4 domain of Bcl-2. Cell Death Dis. 2013, 4:e632.
125. Chang M.J., Zhong F., Lavik A.R., Parys J.B., Berridge M.J., Distelhorst C.W. Feedback regulation mediated by Bcl-2 and DARPP-32 regulates inositol 1,4,5-trisphosphate receptor phosphorylation and promotes cell survival. Proc. Natl. Acad. Sci. U. S. A. 2014, 111:1186-1191.
126. Walaas S.I., Hemmings H.C., Greengard P., Nairn A.C. Beyond the dopamine receptor: regulation and roles of serine/threonine protein phosphatases. Front. Neuroanat. 2011, 5:50.
127. Erin N., Billingsley M.L. Domoic acid enhances Bcl-2-calcineurin-inositol-1,4,5-trisphosphate receptor interactions and delayed neuronal death in rat brain slices. Brain Res. 2004, 1014:45-52.
128. 2+ analyzed with an improved genetically encoded fluorescent sensor. Proc. Natl. Acad. Sci. U. S. A. 2004, 101:17404-17409.
129. 2+ uptake. J. Biol. Chem. 2013, 288:19870-19881.
130. Winter J.N., Andersen J., Reed J.C., Krajewski S., Variakojis D., Bauer K.D., Fisher R.I., Gordon L.I., Oken M.M., Jiang S., Jeffries D., Domer P. Bcl-2 expression correlates with lower proliferative activity in the intermediate- and high-grade non-Hodgkin's lymphomas: an Eastern Cooperative Oncology Group and Southwest Oncology Group cooperative laboratory study. Blood 1998, 91:1391-1398.
131. Wilson W.H., Teruya-Feldstein J., Fest T., Harris C., Steinberg S.M., Jaffe E.S., Raffeld M. Relationship of p53, Bcl-2, and tumor proliferation to clinical drug resistance in non-Hodgkin's lymphomas. Blood 1997, 89:601-609.
132. Marvel J., Perkins G.R., Lopez Rivas A., Collins M.K. Growth factor starvation of Bcl-2 overexpressing murine bone marrow cells induced refractoriness to IL-3 stimulation of proliferation. Oncogene 1994, 9:1117-1122.
133. Linette G.P., Li Y., Roth K., Korsmeyer S.J. Cross talk between cell death and cell cycle progression: Bcl-2 regulates NFAT-mediated activation. Proc. Natl. Acad. Sci. U. S. A. 1996, 93:9545-9552.
134. Borner C. Diminished cell proliferation associated with the death-protective activity of Bcl-2. J. Biol. Chem. 1996, 271:12695-12698.
135. Yamamoto K., Ichijo H., Korsmeyer S.J. Bcl-2 is phosphorylated and inactivated by an ASK1/Jun N-terminal protein kinase pathway normally activated at G(2)/M. Mol. Cell. Biol. 1999, 19:8469-8478.
136. 2+ homeostasis and apoptosis. EMBO J. 2004, 23:1207-1216.
137. Huang D.C., O'Reilly L.A., Strasser A., Cory S. The anti-apoptosis function of Bcl-2 can be genetically separated from its inhibitory effect on cell cycle entry. EMBO J. 1997, 16:4628-4638.
138. Otake Y., Soundararajan S., Sengupta T.K., Kio E.A., Smith J.C., Pineda-Roman M., Stuart R.K., Spicer E.K., Fernandes D.J. Overexpression of nucleolin in chronic lymphocytic leukemia cells induces stabilization of Bcl-2 mRNA. Blood 2007, 109:3069-3075.
139. Kelly P.N., Strasser A. The role of Bcl-2 and its pro-survival relatives in tumourigenesis and cancer therapy. Cell Death Differ. 2011, 18:1414-1424.
140. Chresta C.M., Arriola E.L., Hickman J.A. Apoptosis and cancer chemotherapy. Behring Inst. Mitt. 1996, 232-240.
141. Behbahani T.E., Thierse C., Baumann C., Holl D., Bastian P.J., von Ruecker A., Muller S.C., Ellinger J., Hauser S. Tyrosine kinase expression profile in clear cell renal cell carcinoma. World J. Urol. 2012, 30:559-565.
142. Chao D.T., Korsmeyer S.J. Bcl-2 family: regulators of cell death. Annu. Rev. Immunol. 1998, 16:395-419.
143. Cory S., Adams J.M. The Bcl-2 family: regulators of the cellular life-or-death switch. Nat. Rev. Cancer 2002, 2:647-656.
144. Calin G.A., Cimmino A., Fabbri M., Ferracin M., Wojcik S.E., Shimizu M., Taccioli C., Zanesi N., Garzon R., Aqeilan R.I., Alder H., Volinia S., Rassenti L., Liu X., Liu C.G., Kipps T.J., Negrini M., Croce C.M. MiR-15a and miR-16-1 cluster functions in human leukemia. Proc. Natl. Acad. Sci. U. S. A. 2008, 105:5166-5171.
145. Sasaki N., Kuroda J., Nagoshi H., Yamamoto M., Kobayashi S., Tsutsumi Y., Kobayashi T., Shimura Y., Matsumoto Y., Taki T., Nishida K., Horiike S., Akao Y., Taniwaki M. Bcl-2 is a better therapeutic target than c-Myc, but attacking both could be a more effective treatment strategy for B-cell lymphoma with concurrent Bcl-2 and c-Myc overexpression. Exp. Hematol. 2011, 39:817-828. (e811).
146. Di Lisio L., Sanchez-Beato M., Gomez-Lopez G., Rodriguez M.E., Montes-Moreno S., Mollejo M., Menarguez J., Martinez M.A., Alves F.J., Pisano D.G., Piris M.A., Martinez N. MicroRNA signatures in B-cell lymphomas. Blood Cancer J. 2012, 2:e57.
147. Calin G.A., Pekarsky Y., Croce C.M. The role of microRNA and other non-coding RNA in the pathogenesis of chronic lymphocytic leukemia. Best Pract. Res. Clin. Haematol. 2007, 20:425-437.
148. Cimmino A., Calin G.A., Fabbri M., Iorio M.V., Ferracin M., Shimizu M., Wojcik S.E., Aqeilan R.I., Zupo S., Dono M., Rassenti L., Alder H., Volinia S., Liu C.G., Kipps T.J., Negrini M., Croce C.M. miR-15 and miR-16 induce apoptosis by targeting Bcl-2. Proc. Natl. Acad. Sci. U. S. A. 2005, 102:13944-13949.
149. Di Lisio L., Martinez N., Montes-Moreno S., Piris-Villaespesa M., Sanchez-Beato M., Piris M.A. The role of miRNAs in the pathogenesis and diagnosis of B-cell lymphomas. Blood 2012, 120:1782-1790.
150. Hanahan D., Weinberg R.A. Hallmarks of cancer: the next generation. Cell 2011, 144:646-674.
151. Del Gaizo Moore V., Schlis K.D., Sallan S.E., Armstrong S.A., Letai A. Bcl-2 dependence and ABT-737 sensitivity in acute lymphoblastic leukemia. Blood 2008, 111:2300-2309.
152. Letai A.G. Diagnosing and exploiting cancer's addiction to blocks in apoptosis. Nat. Rev. Cancer 2008, 8:121-132.
153. Vo T.T., Ryan J., Carrasco R., Neuberg D., Rossi D.J., Stone R.M., Deangelo D.J., Frattini M.G., Letai A. Relative mitochondrial priming of myeloblasts and normal HSCs determines chemotherapeutic success in AML. Cell 2012, 151:344-355.
154. Cleary M., Rosenberg S.A. The Bcl-2 gene, follicular lymphoma, and Hodgkin's disease. J. Natl. Cancer Inst. 1990, 82:808-809.
155. Lipponen P., Pietilainen T., Kosma V.M., Aaltomaa S., Eskelinen M., Syrjanen K. Apoptosis suppressing protein Bcl-2 is expressed in well-differentiated breast carcinomas with favourable prognosis. J. Pathol. 1995, 177:49-55.
156. Belanger S., Cote M., Lane D., L'Esperance S., Rancourt C., Piche A. Bcl-2 decreases cell proliferation and promotes accumulation of cells in S phase without affecting the rate of apoptosis in human ovarian carcinoma cells. Gynecol. Oncol. 2005, 97:796-806.
157. Certo M., Del Gaizo Moore V., Nishino M., Wei G., Korsmeyer S., Armstrong S.A., Letai A. Mitochondria primed by death signals determine cellular addiction to antiapoptotic Bcl-2 family members. Cancer Cell 2006, 9:351-365.
158. Deng J., Carlson N., Takeyama K., Dal Cin P., Shipp M., Letai A. BH3 profiling identifies three distinct classes of apoptotic blocks to predict response to ABT-737 and conventional chemotherapeutic agents. Cancer Cell 2007, 12:171-185.
159. Del Gaizo Moore V., Letai A. BH3 profiling-measuring integrated function of the mitochondrial apoptotic pathway to predict cell fate decisions. Cancer Lett. 2013, 332:202-205.
160. Chen L., Willis S.N., Wei A., Smith B.J., Fletcher J.I., Hinds M.G., Colman P.M., Day C.L., Adams J.M., Huang D.C. Differential targeting of prosurvival Bcl-2 proteins by their BH3-only ligands allows complementary apoptotic function. Mol. Cell 2005, 17:393-403.
161. Ni Chonghaile T., Sarosiek K.A., Vo T.T., Ryan J.A., Tammareddi A., Moore Vdel G., Deng J., Anderson K.C., Richardson P., Tai Y.T., Mitsiades C.S., Matulonis U.A., Drapkin R., Stone R., Deangelo D.J., McConkey D.J., Sallan S.E., Silverman L., Hirsch M.S., Carrasco D.R., Letai A. Pretreatment mitochondrial priming correlates with clinical response to cytotoxic chemotherapy. Science 2011, 334:1129-1133.
162. Davids M.S., Letai A. Targeting the B-cell lymphoma/leukemia 2 family in cancer. J. Clin. Oncol. 2012, 30:3127-3135.
163. Fesik S.W. Promoting apoptosis as a strategy for cancer drug discovery. Nat. Rev. Cancer 2005, 5:876-885.
164. Chonghaile T.N., Letai A. Mimicking the BH3 domain to kill cancer cells. Oncogene 2008, 27(Suppl. 1):S149-S157.
165. Oltersdorf T., Elmore S.W., Shoemaker A.R., Armstrong R.C., Augeri D.J., Belli B.A., Bruncko M., Deckwerth T.L., Dinges J., Hajduk P.J., Joseph M.K., Kitada S., Korsmeyer S.J., Kunzer A.R., Letai A., Li C., Mitten M.J., Nettesheim D.G., Ng S., Nimmer P.M., O'Connor J.M., Oleksijew A., Petros A.M., Reed J.C., Shen W., Tahir S.K., Thompson C.B., Tomaselli K.J., Wang B., Wendt M.D., Zhang H., Fesik S.W., Rosenberg S.H. An inhibitor of Bcl-2 family proteins induces regression of solid tumours. Nature 2005, 435:677-681.
166. Souers A.J., Leverson J.D., Boghaert E.R., Ackler S.L., Catron N.D., Chen J., Dayton B.D., Ding H., Enschede S.H., Fairbrother W.J., Huang D.C., Hymowitz S.G., Jin S., Khaw S.L., Kovar P.J., Lam L.T., Lee J., Maecker H.L., Marsh K.C., Mason K.D., Mitten M.J., Nimmer P.M., Oleksijew A., Park C.H., Park C.M., Phillips D.C., Roberts A.W., Sampath D., Seymour J.F., Smith M.L., Sullivan G.M., Tahir S.K., Tse C., Wendt M.D., Xiao Y., Xue J.C., Zhang H., Humerickhouse R.A., Rosenberg S.H., Elmore S.W. ABT-199, a potent and selective Bcl-2 inhibitor, achieves antitumor activity while sparing platelets. Nat. Med. 2013, 19:202-208.
167. Gandhi L., Camidge D.R., Ribeiro de Oliveira M., Bonomi P., Gandara D., Khaira D., Hann C.L., McKeegan E.M., Litvinovich E., Hemken P.M., Dive C., Enschede S.H., Nolan C., Chiu Y.L., Busman T., Xiong H., Krivoshik A.P., Humerickhouse R., Shapiro G.I., Rudin C.M. Phase I study of Navitoclax (ABT-263), a novel Bcl-2 family inhibitor, in patients with small-cell lung cancer and other solid tumors. J. Clin. Oncol. 2011, 29:909-916.
168. Rudin C.M., Hann C.L., Garon E.B., Ribeiro de Oliveira M., Bonomi P.D., Camidge D.R., Chu Q., Giaccone G., Khaira D., Ramalingam S.S., Ranson M.R., Dive C., McKeegan E.M., Chyla B.J., Dowell B.L., Chakravartty A., Nolan C.E., Rudersdorf N., Busman T.A., Mabry M.H., Krivoshik A.P., Humerickhouse R.A., Shapiro G.I., Gandhi L. Phase II study of single-agent navitoclax (ABT-263) and biomarker correlates in patients with relapsed small cell lung cancer. Clin. Cancer Res. 2012, 18:3163-3169.
169. Qi B., Hardwick J.M. A Bcl-Xl timer sets platelet life span. Cell 2007, 128:1035-1036.
170. Schoenwaelder S.M., Jarman K.E., Gardiner E.E., Hua M., Qiao J., White M.J., Josefsson E.C., Alwis I., Ono A., Willcox A., Andrews R.K., Mason K.D., Salem H.H., Huang D.C., Kile B.T., Roberts A.W., Jackson S.P. Bcl-Xl-inhibitory BH3 mimetics can induce a transient thrombocytopathy that undermines the hemostatic function of platelets. Blood 2011, 118:1663-1674.
171. Vogler M., Hamali H.A., Sun X.M., Bampton E.T., Dinsdale D., Snowden R.T., Dyer M.J., Goodall A.H., Cohen G.M. Bcl-2/Bcl-Xl inhibition induces apoptosis, disrupts cellular calcium homeostasis, and prevents platelet activation. Blood 2011, 117:7145-7154.
172. Roberts A.W., Seymour J.F., Brown J.R., Wierda W.G., Kipps T.J., Khaw S.L., Carney D.A., He S.Z., Huang D.C., Xiong H., Cui Y., Busman T.A., McKeegan E.M., Krivoshik A.P., Enschede S.H., Humerickhouse R. Substantial susceptibility of chronic lymphocytic leukemia to Bcl-2 inhibition: results of a phase I study of navitoclax in patients with relapsed or refractory disease. J. Clin. Oncol. 2012, 30:488-496.
173. Schoenwaelder S.M., Jackson S.P. Bcl-Xl-inhibitory BH3 mimetics (ABT-737 or ABT-263) and the modulation of cytosolic calcium flux and platelet function. Blood 2012, 119:1320-1321. (author reply 1321-1322).
174. Hermanson D., Addo S.N., Bajer A.A., Marchant J.S., Das S.G., Srinivasan B., Al-Mousa F., Michelangeli F., Thomas D.D., Lebien T.W., Xing C. Dual mechanisms of sHA 14-1 in inducing cell death through endoplasmic reticulum and mitochondria. Mol. Pharmacol. 2009, 76:667-678.
175. 2+ dysregulation in platelets and human cell lines. Haematologica 2013, 98:e49-e51.
176. Touzeau C., Dousset C., Le Gouill S., Sampath D., Leverson J.D., Souers A.J., Maiga S., Bene M.C., Moreau P., Pellat-Deceunynck C., Amiot M. The Bcl-2 specific BH3 mimetic ABT-199: a promising targeted therapy for t(11;14) multiple myeloma. Leukemia 2014, 28:210-212.
177. Vaillant F., Merino D., Lee L., Breslin K., Pal B., Ritchie M.E., Smyth G.K., Christie M., Phillipson L.J., Burns C.J., Mann G.B., Visvader J.E., Lindeman G.J. Targeting Bcl-2 with the BH3 mimetic ABT-199 in estrogen receptor-positive breast cancer. Cancer Cell 2013, 24:120-129.
178. Brumatti G., Ekert P.G. Seeking a MCL-1 inhibitor. Cell Death Differ. 2013, 20:1440-1441.
179. Scholl F.A., Dumesic P.A., Barragan D.I., Harada K., Bissonauth V., Charron J., Khavari P.A. Mek1/2 MAPK kinases are essential for mammalian development, homeostasis, and Raf-induced hyperplasia. Dev. Cell 2007, 12:615-629.
180. Chu E.C., Tarnawski A.S. PTEN regulatory functions in tumor suppression and cell biology. Med. Sci. Monit. 2004, 10:RA235-RA241.
181. Balmanno K., Cook S.J. Tumour cell survival signalling by the ERK1/2 pathway. Cell Death Differ. 2009, 16:368-377.
182. Puthalakath H., Strasser A. Keeping killers on a tight leash: transcriptional and post-translational control of the pro-apoptotic activity of BH3-only proteins. Cell Death Differ. 2002, 9:505-512.
183. Selimoglu-Buet D., Gallais I., Denis N., Guillouf C., Moreau-Gachelin F. Oncogenic kit triggers Shp2/Erk1/2 pathway to down-regulate the pro-apoptotic protein Bim and to promote apoptosis resistance in leukemic cells. PLoS One 2012, 7:e49052.
184. 2+ stores in pancreatic acinar cells. Pflugers Arch. 2010, 460:891-900.
185. Vogler M., Weber K., Dinsdale D., Schmitz I., Schulze-Osthoff K., Dyer M.J., Cohen G.M. Different forms of cell death induced by putative Bcl-2 inhibitors. Cell Death Differ. 2009, 16:1030-1039.
186. 3 receptor subtypes. EMBO J. 1999, 18:1303-1308.
187. Sano R., Reed J.C. ER stress-induced cell death mechanisms. Biochim. Biophys. Acta (BBA)-Mol. Cell Res. 2013, 1833:3460-3470.
188. Urra H., Dufey E., Lisbona F., Rojas-Rivera D., Hetz C. When ER stress reaches a dead end. Biochim. Biophys. Acta (BBA) - Mol. Cell Res. 2013, 1833:3507-3517.
189. Davis R.E., Ngo V.N., Lenz G., Tolar P., Young R.M., Romesser P.B., Kohlhammer H., Lamy L., Zhao H., Yang Y., Xu W., Shaffer A.L., Wright G., Xiao W., Powell J., Jiang J.K., Thomas C.J., Rosenwald A., Ott G., Muller-Hermelink H.K., Gascoyne R.D., Connors J.M., Johnson N.A., Rimsza L.M., Campo E., Jaffe E.S., Wilson W.H., Delabie J., Smeland E.B., Fisher R.I., Braziel R.M., Tubbs R.R., Cook J.R., Weisenburger D.D., Chan W.C., Pierce S.K., Staudt L.M. Chronic active B-cell-receptor signalling in diffuse large B-cell lymphoma. Nature 2010, 463:88-92.
190. Duhren-von Minden M., Ubelhart R., Schneider D., Wossning T., Bach M.P., Buchner M., Hofmann D., Surova E., Follo M., Kohler F., Wardemann H., Zirlik K., Veelken H., Jumaa H. Chronic lymphocytic leukaemia is driven by antigen-independent cell-autonomous signalling. Nature 2012, 489:309-312.
191. Uddin S., Hussain A.R., Siraj A.K., Manogaran P.S., Al-Jomah N.A., Moorji A., Atizado V., Al-Dayel F., Belgaumi A., El-Solh H., Ezzat A., Bavi P., Al-Kuraya K.S. Role of phosphatidylinositol 3'-kinase/Akt pathway in diffuse large B-cell lymphoma survival. Blood 2006, 108:4178-4186.
192. 2+ initiation site of ductal epithelium of submandibular gland. J. Cell Biol. 1998, 141:135-142.
193. 2+ release to ATP in pancreatic acinar cells. J. Biol. Chem. 2008, 283:26081-26088.
194. 2+ oscillations induced by ATP in Chinese hamster ovary cells. J. Biol. Chem. 1997, 272:17367-17375.
195. Hayashi T., Hirshman M.F., Fujii N., Habinowski S.A., Witters L.A., Goodyear L.J. Metabolic stress and altered glucose transport: activation of AMP-activated protein kinase as a unifying coupling mechanism. Diabetes 2000, 49:527-531.
196. Kilpinen S., Autio R., Ojala K., Iljin K., Bucher E., Sara H., Pisto T., Saarela M., Skotheim R.I., Bjorkman M., Mpindi J.P., Haapa-Paananen S., Vainio P., Edgren H., Wolf M., Astola J., Nees M., Hautaniemi S., Kallioniemi O. Systematic bioinformatic analysis of expression levels of 17,330 human genes across 9,783 samples from 175 types of healthy and pathological tissues. Genome Biol. 2008, 9:R139.
197. Autio R., Kilpinen S., Saarela M., Kallioniemi O., Hautaniemi S., Astola J. Comparison of Affymetrix data normalization methods using 6,926 experiments across five array generations. BMC Bioinforma. 2009, 10(Suppl. 1):S24.